These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34836909)

  • 1. FLUID study: study protocol for an open-label, single-centre pilot study to investigate the efFect of Lemborexant on sleep management in Japanese sUbjects aged 50 years and older with Insomnia Disorder.
    Okada I; Iwamoto K; Miyata S; Fujimoto A; Tanaka M; Amano M; Matsuyama N; Taoka T; Naganawa S; Ozaki N
    BMJ Open; 2021 Nov; 11(11):e054885. PubMed ID: 34836909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.
    Chepke C; Jain R; Rosenberg R; Moline M; Yardley J; Pinner K; Kumar D; Perdomo C; Filippov G; Atkins N; Malhotra M
    Postgrad Med; 2022 Apr; 134(3):316-325. PubMed ID: 35254948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Cheng JY; Moline M; Zammit GK; Filippov G; Bsharat M; Hall N
    Clin Drug Investig; 2021 May; 41(5):449-457. PubMed ID: 33723806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial.
    Yardley J; Kärppä M; Inoue Y; Pinner K; Perdomo C; Ishikawa K; Filippov G; Kubota N; Moline M
    Sleep Med; 2021 Apr; 80():333-342. PubMed ID: 33636648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials.
    Moline M; Zammit G; Yardley J; Pinner K; Kumar D; Perdomo C; Cheng JY
    Postgrad Med; 2021 Jan; 133(1):71-81. PubMed ID: 33119423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study.
    Inoue Y; Watanabe T; Takashima S; Takase T; Ishikawa K; Kubota N; Yardley J; Moline M
    J Clin Sleep Med; 2021 May; 17(5):1067-1074. PubMed ID: 33576735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial.
    Moline M; Thein S; Bsharat M; Rabbee N; Kemethofer-Waliczky M; Filippov G; Kubota N; Dhadda S
    J Prev Alzheimers Dis; 2021; 8(1):7-18. PubMed ID: 33336219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preclinical and clinical efficacy of orexin receptor antagonist Lemborexant (Dayvigo
    Koebisu M; Koyama N; Nishida M; Muramoto K
    Nihon Yakurigaku Zasshi; 2021; 156(2):114-119. PubMed ID: 33642529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating lemborexant for the treatment of insomnia.
    Zammit G; Krystal A
    Expert Opin Pharmacother; 2021 Jul; 22(10):1235-1243. PubMed ID: 33711243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder.
    Moline M; Zammit G; Cheng JY; Perdomo C; Kumar D; Mayleben D
    J Clin Sleep Med; 2021 Jun; 17(6):1167-1174. PubMed ID: 33590823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
    Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
    J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium.
    Terada T; Hirayama T; Sadahiro R; Wada S; Nakahara R; Matsuoka H
    J Palliat Med; 2022 May; 25(5):797-801. PubMed ID: 35099287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture for treating insomnia in patients with cancer: a study protocol for a randomised pilot clinical trial.
    Kim M; Kim JE; Lee HY; Kim AR; Park HJ; Kwon OJ; Kim BK; Cho JH; Kim JH
    BMJ Open; 2017 Aug; 7(8):e016269. PubMed ID: 28801421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Review of Lemborexant to Treat Insomnia.
    Fuller MC; Carlson SF; Grant C; Berry V; Ivancich M; Cornett EM; Kaye AM; Viswanath O; Urits I; Shekoohi S; Kaye AD
    Psychopharmacol Bull; 2024 Mar; 54(1):43-64. PubMed ID: 38449475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2.
    Kärppä M; Yardley J; Pinner K; Filippov G; Zammit G; Moline M; Perdomo C; Inoue Y; Ishikawa K; Kubota N
    Sleep; 2020 Sep; 43(9):. PubMed ID: 32585700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of low-dose amitriptyline and mirtazapine for insomnia disorder: study protocol of a randomised, double-blind, placebo-controlled trial in general practice (the DREAMING study).
    Bakker MH; Hugtenburg JG; van Straten A; van der Horst HE; Slottje P
    BMJ Open; 2021 Sep; 11(9):e047142. PubMed ID: 34475156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of sleep and pain with lemborexant administration in patients with chronic pain: a retrospective observational study.
    Ueno K; Sato H; Nomura Y; Obata N; Mizobuchi S
    Pain Med; 2024 Feb; 25(2):139-143. PubMed ID: 37707540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
    Beuckmann CT; Ueno T; Nakagawa M; Suzuki M; Akasofu S
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30923834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review.
    Habiba U; Waseem R; Shaikh TG; Waseem S; Ahmed SH; Asghar MS
    Neurol Sci; 2023 May; 44(5):1533-1541. PubMed ID: 36633778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.